Cytidine-13C9,15N3

Cytidine-13C9,15N3 is the 13C and 15N labeled Cytidine[1]. Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[2][3][4].

Product Specifications

CAS Number

[202406-79-9]

Product Name Alternative

Cytosine β-D-riboside-13C9,15N3; Cytosine-1-β-D-ribofuranoside-13C9,15N3

UNSPSC

12352005

Target

Endogenous Metabolite; Nucleoside Antimetabolite/Analog

Type

Isotope-Labeled Compounds

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/cytidine-13c9-15n3.html

Concentration

100 mM in 39.20 μL Tris HCl/H2O buffer pH=7.5

Purity

98.90

Solubility

10 mM in DMSO

Smiles

O[13CH]1[13CH](O)[13C@H]([15N]2[13C]([15N]=[13C]([15NH2])[13CH]=[13CH]2)=O)O[13C@@H]1[13CH2]O

Molecular Formula

13C9H13 15N3O5

Molecular Weight

255.13

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Jonas DA, et al. Safety considerations of DNA in food. Ann Nutr Metab. 2001;45 (6) :235-54.|[3]Machado-Vieira R, et, al. New therapeutic targets for mood disorders. ScientificWorldJournal. 2010 Apr 1310:713-26.